Analysis of the results of allogeneic hematopoietic stem cell transplantation depending on HLA matching of the unrelated donor / recipient pair
https://doi.org/10.17650/1818-8346-2014-9-3-25-31
Abstract
HLA matching of the donor / recipient pair is a major factor associated with the outcome of allogeneic stem cell transplantation. In the present
study we analyzed the risk of severe acute graft-versus-host disease, graft failure, 2.year overall survival of the patients after allogeneic stem cell transplantation depending on HLA matching of the unrelated donor / recipient pair.
About the Authors
Ye. V. Kuzmich
Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation
I. P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
A. I. Alyanskiy
Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation
I. P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
N. Ye. Ivanova
Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation
I. P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
A. A. Vitrischak
Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation
I. P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
M. D. Vladovskaya
Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation
I. P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
Ye. V. Morozova
Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation
I. P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
S. N. Bondarenko
Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation
I. P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
Ye. V. Semenova
Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation
I. P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
L. S. Zubarovskaya
Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation
I. P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
B. V. Afanasyev
Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation
I. P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
References
1. Petersdorf E. W. Risk assessment in hematopoietic stem cell transplantation. Best Pract Res Clin Haematol 2007;20(2):155–70.
2. Standards for Histocompatibility and Immunogenetics Testing – version 6.1, 2013, EFI (http://efiweb.eu / ).
3. Petersdorf E. W., Malkki M., Hsu K. et al. 16th IHIW: International Histocompatibility Working Group in Hematopoietic Cell Transplantation. Int J Immunogenet 2013;40(1):2–10.
4. Flomenberg N., Baxter-Lowe L. A., Confer D. et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004;104(7):1923–30.
5. Kawase T., Morishima Y., Matsuo K. et al. High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. Blood 2007;110(7):2235–41.
6. Lee S. J., Klein J., Haagenson M. et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007;110(13):4576–83.
7. Morishima Y., Yabe T., Matsuo K. et al. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor. Biol Blood Marrow Transplant 2007;13(3):315–28.
8. Park M., Koh K. N., Kim B. E. et al. The impact of HLA matching on unrelated donor hematopoietic stem cell transplantation in Korean children. Korean J Hematol 2011;46(1):11–7.
9. Tiercy J. M., Passweg J., Van Biezen A. et al. Isolated HLA-C mismatches in unrelated donor transplantation for CML. Bone Marrow Transplant 2004; 34(3):249–55.
10. Shaw B. E., Arguello R., Garcia-Sepulveda Ch. A. et al. The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation. Br J Haematol 2010;150(3):251–8.
11. Woolfrey A., Klein J. P., Haagenson M. et al. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2011;17(6):885–92.
12. Yagasaki H., Kojima S., Yabe H. et al. Acceptable HLA-mismatching in unrelated donor bone marrow transplantation for patients with acquired severe aplastic anemia. Blood 2011;118(11):3186–90.
13. Glucksberg H., Storb R., Fefer A. et al. Clinical manifestations of graft-vs-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974;18(4):295–304.
Review
For citations:
Kuzmich Ye.V., Alyanskiy A.I., Ivanova N.Ye., Vitrischak A.A., Vladovskaya M.D., Morozova Ye.V., Bondarenko S.N., Semenova Ye.V., Zubarovskaya L.S., Afanasyev B.V. Analysis of the results of allogeneic hematopoietic stem cell transplantation depending on HLA matching of the unrelated donor / recipient pair. Oncohematology. 2014;9(3):25-31. (In Russ.) https://doi.org/10.17650/1818-8346-2014-9-3-25-31
Views:
9963
Email this article 